S Squared Technology LLC Trims Stake in DocGo Inc. (NASDAQ:DCGO)

S Squared Technology LLC lessened its holdings in DocGo Inc. (NASDAQ:DCGO - Free Report) by 15.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,382,386 shares of the company's stock after selling 255,000 shares during the period. DocGo makes up 2.4% of S Squared Technology LLC's investment portfolio, making the stock its 18th largest position. S Squared Technology LLC owned 1.35% of DocGo worth $5,861,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. WCM Investment Management LLC boosted its stake in shares of DocGo by 64.2% in the 4th quarter. WCM Investment Management LLC now owns 4,314,071 shares of the company's stock valued at $18,637,000 after buying an additional 1,687,100 shares during the period. American Century Companies Inc. lifted its position in DocGo by 490.3% in the fourth quarter. American Century Companies Inc. now owns 452,254 shares of the company's stock valued at $1,918,000 after acquiring an additional 375,637 shares during the last quarter. Harbor Capital Advisors Inc. increased its position in shares of DocGo by 37.5% during the fourth quarter. Harbor Capital Advisors Inc. now owns 1,331,928 shares of the company's stock worth $5,647,000 after purchasing an additional 363,391 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of DocGo by 583.4% in the 4th quarter. Renaissance Technologies LLC now owns 350,600 shares of the company's stock valued at $1,487,000 after purchasing an additional 299,300 shares during the last quarter. Finally, First Eagle Investment Management LLC acquired a new position in DocGo during the fourth quarter worth approximately $1,116,000. 56.44% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Needham & Company LLC reaffirmed a "buy" rating and issued a $4.00 target price on shares of DocGo in a report on Tuesday, April 8th. Deutsche Bank Aktiengesellschaft downgraded DocGo from a "buy" rating to a "hold" rating and lowered their target price for the company from $5.00 to $2.85 in a research note on Friday, February 28th. Finally, Stifel Nicolaus decreased their price target on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a report on Friday, February 28th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, DocGo presently has a consensus rating of "Moderate Buy" and an average price target of $4.89.

DocGo Stock Performance

DCGO stock traded up $0.07 during trading on Tuesday, reaching $2.14. 190,948 shares of the company were exchanged, compared to its average volume of 747,926. DocGo Inc. has a 52-week low of $2.02 and a 52-week high of $5.68. The company has a market cap of $217.73 million, a P/E ratio of 7.66, a PEG ratio of 14.16 and a beta of 1.12. The stock's 50 day moving average price is $3.16 and its 200 day moving average price is $3.79.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.